Search

Search results




Lived experience at the heart of innovation

ADI calls for lived experience to be central to innovation in the field of dementia diagnostics, treatment and care. In her short interview with Novartis, Paola Barbarino highlights key areas which innovators must consider when developing their products and service, from inception, to testing and ultimately bringing them to market; and reminds us not to forget that simple innovative changes can lead to great impact.

Alzheimers Disease International (ADI)

Vision & strategy

ADI's vision, mission and values define what we do. We have a 3 year strategic plan which guides our work.

Our history

ADI's history from its foundation in 1984 to the present. How ADI has grown to be the worldwide federation of over 100 Alzheimer associations.

Paola Barbarino and Queen Silvia

Queen Silvia of Sweden becomes ADI Ambassador

Her Majesty Queen Silvia of Sweden has become an Honorary Ambassador of Alzheimer’s Disease International (ADI), in recognition of her personal commitment to work surrounding elderly and end of life care, and specifically dementia. Queen Silvia has a long-standing association with and in support of dementia. In 1996, she initiated…

ADI invites Biogen to present aducanumab data

This webinar focuses on the clinical trial data for Biogen’s investigational drug aducanumab. If approved, aducanumab would be the first disease-modifying treatment for Alzheimer’s disease.

Regional member meetings for Latin America and Asia Pacific

ADI hosted its first virtual regional meeting for ADI members in Latin America, since the COVID-19 pandemic began, on 12 November. The second virtual regional meeting Asia Pacific took place a week later on 12 November. During the Latin America meeting, 18 participants from 13 countries were in attendance. The 2-hour meeting…